Your browser doesn't support javascript.
loading
Contemporary outcomes of high risk relapsed refractory classical hodgkin lymphoma patients-role of maintenance therapy in the real world.
Damlaj, Moussab; Tlayjeh, Mohamed; Damlaj, Ahmad; Alahmari, Bader; AlSadi, Husam; Ahmed, Mazin; AlJubour, Zied; Alhejazi, Ayman; Salama, Hend; Ibrahim, Ayman; Al Raizah, Abdulrahman; Bakkar, Mohammed; Ghori, Abdulraouf; Al Saleh, Abdullah S; Alaskar, Ahmed; Alzahrani, Mohsen.
Afiliación
  • Damlaj M; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia. mdamlaj@gmail.com.
  • Tlayjeh M; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. mdamlaj@gmail.com.
  • Damlaj A; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. mdamlaj@gmail.com.
  • Alahmari B; Sheikh Shakhbout Medical City, Abu Dhabi, UAE. mdamlaj@gmail.com.
  • AlSadi H; Khalifa University, Abu Dhabi, UAE. mdamlaj@gmail.com.
  • Ahmed M; Alfaisal University, Riyadh, Saudi Arabia.
  • AlJubour Z; American University of Beirut, Beirut, Lebanon.
  • Alhejazi A; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Salama H; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Ibrahim A; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Al Raizah A; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Bakkar M; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Ghori A; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Al Saleh AS; Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alaskar A; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alzahrani M; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Bone Marrow Transplant ; 58(10): 1160-1162, 2023 10.
Article en En | MEDLINE | ID: mdl-37464089
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Antineoplásicos Inmunológicos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Antineoplásicos Inmunológicos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita